A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present)-Reference-Cited by-同舟云学术

A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present)

Published:2020-02-26 Issue:5 Volume:30 Page:341-350
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Guo Jing¹^ORCID,Zhang Zhen¹,Ding Ke¹^ORCID

Affiliation:

1. International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2020.1732925

Reference55 articles.

1. Sensing extracellular matrix: An update on discoidin domain receptor function

2. Discoidin domain receptors: structural relations and functional implications

3. Collagen recognition and transmembrane signalling by discoidin domain receptors

4. Discoidin Domain Receptor 1 Tyrosine Kinase Has an Essential Role in Mammary Gland Development

5. Crystallographic Insight into Collagen Recognition by Discoidin Domain Receptor 2

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DDR1-targeted therapies: current limitations and future potential;Drug Discovery Today;2024-05

2. Design, synthesis, and biological evaluation of novel discoidin domain receptor inhibitors for the treatment of lung adenocarcinoma and pulmonary fibrosis;European Journal of Medicinal Chemistry;2024-02

3. Discoidin domain receptor 1 as a potent therapeutic target in solid tumors;hLife;2024-01

4. Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties;Bioorganic Chemistry;2023-06

5. A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer;Journal for ImmunoTherapy of Cancer;2023-06